Email Updates

You are here

Home

AVAC's Blog: P-Values

  • May Episode of Px Pulse Podcast: HIV vaccine science, research, updates and advocacy

    With HIV Vaccine Awareness Day (HVAD) in the spotlight earlier this month, AVAC’s May episode of Px Pulse features four experts steeped in HIV vaccine research. Together they help set expectations for where the field is now and where it is going.

    May 31, 2018
    HIV Vaccine
    AVAC

  • HIV Vaccine Awareness Day 2018: Tools & more

    HIV Vaccine Awareness Day, May 18, commemorates the vital and ongoing work to develop a vaccine against HIV. This work advances because of the ingenuity, courage and commitment of trial participants, host communities, funders, scientists and advocates. AVAC salutes the collective trust and sustained dedication to end the epidemic.

    May 18, 2018
    Antibody Related Research, HIV Vaccine
    AVAC

  • The Rise of Broadly Neutralizing Antibodies

    Research on broadly neutralizing antibodies (bNAbs) is taking the field of HIV prevention science in new directions, with implications for new prevention interventions and vaccine development. There’s much to know and much to learn about these powerful instruments of the immune system.

    May 17, 2018
    Antibody Related Research, HIV Vaccine
    Bill Snow

  • HIV Vaccine Awareness Day: In May 2018, the story is…

    With HIV Vaccine Awareness Day (HVAD) just around the corner, AVAC has several announcements — updates to our annual HVAD toolkit, a new advocacy resource and our May 17 webinar on the current state of HIV vaccine research from two perspectives.

    May 11, 2018
    HIV Vaccine

  • New Issue! Px Wire: The prevention question cascade

    In the new issue of Px Wire, AVAC gives our take on this year’s PEPFAR process for establishing the Country Operational Plans (COPs). These plans define what work will be done with PEPFAR money at the country level and how that work will be evaluated in each of the 63 countries that receive PEPFAR money.

    May 3, 2018
    Combination Prevention, General, PrEP, Treatment, Voluntary Medical Male Circumcision
    AVAC

  • Px Pulse Podcast: From the trenches, advocates share their prevention priorities

    In this episode of Px Pulse, our monthly podcast, we bring you two different conversations, each throwing a spotlight on different aspects of HIV prevention advocacy today. You'll hear how the AVAC Partner Forum brought key issues into focus and how these advocates are sharpening their strategies. Then we turn to a global effort to accelerate prevention.

    April 30, 2018
    Combination Prevention, Microbicides, PrEP
    AVAC

  • Post-CROI Roundup and Webinar Series

    The annual Conference on Retroviruses and Opportunistic Infections featured over 4,000 researchers, advocates, implementers—and a couple big snowstorms—along with a range of scientific findings of great interest to prevention advocates. Join us to dig into the data with researchers and discuss with fellow advocates how these findings can inform our advocacy work moving forward.

    April 18, 2018
    General
    AVAC

  • CROI 2018: Research for the Front Lines

    Rob Newells, Executive Director of the AIDS Project of the East Bay, gives his personal (US-centered, black MSM-focused) highlights from CROI 2018.

    April 5, 2018
    Microbicides, PrEP, Treatment
    Rob Newells

  • 4/18 Webinar: Introducing Oral PrEP

    At CROI 2018 we heard stories, saw new data, and had lots of questions about early PrEP rollout. Please join AVAC and partners from Jilinde in Kenya and PZAT in Zimbabwe for an upcoming webinar on Wednesday, April 18, 9am ET to explore valuable resources for people working to deliver oral PrEP. See below for some of the tools and resources we will explore and discuss during the webinar. Check them out and come with your questions!

    April 4, 2018
    PrEP
    AVAC

  • Px Pulse Podcast: What's next for the dapivirine ring

    In this episode of Px Pulse, Zeda Rosenberg of IPM explains the latest findings and spells out how, when, where and if the ring might become an available tool. A trial participant and community leader in Uganda pulls back the curtain on the ups and downs of using the ring, and a Ugandan investigator with the REACH study explains the importance of this trial.

    March 30, 2018
    Microbicides, PrEP
    AVAC

Pages

view more